{
    "clinical_study": {
        "@rank": "53659", 
        "arm_group": [
            {
                "arm_group_label": "Normotensive patients", 
                "arm_group_type": "Experimental", 
                "description": "To find out the effect site concentration of remifentanil for preventing QTc prolongation < 15 sec during intubation : Dixon's up-and-down method"
            }, 
            {
                "arm_group_label": "Hypertensive patients", 
                "arm_group_type": "Experimental", 
                "description": "To find out the effect site concentration of remifentanil for preventing QTc prolongation < 15 sec during intubation : Dixon's up-and-down method"
            }
        ], 
        "brief_summary": {
            "textblock": "To find out the effect site concentration of remifentanil for preventing QTc interval\n      prolongation during intubation under propofol-remifentanil anesthesia in normotensive and\n      hypertensive patients"
        }, 
        "brief_title": "The Effect Site Concentration of Remifentanil for Preventing QTc Interval Prolongation During Intubation in Normotensive and Hypertensive Patients", 
        "condition": "Intubation, Intratracheal", 
        "detailed_description": {
            "textblock": "It is known that anesthetic agents can influence the QTc. In addition, tracheal intubation\n      during induction can stimulates sympathetic activity, which, as a results, prolong the QTc\n      interval. Therefore, the aim of study is to find out the effect site concentration of\n      remifentanil for preventing QTc interval prolongation during intubation under\n      propofol-remifentanil anesthesia in normotensive and hypertensive patients."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  \u2265 50 years ASA class I-II female who received surgery with endotracheal intubation\n\n        Exclusion Criteria:\n\n          -  emergency surgery electrocardiography abnormality diabetes mellitus end stage renal\n             disease moderate to severe cardiac disease moderate to severe liver dysfunction\n             systolic blood pressure \u2265 140 mmHg or diastolic blood pressure \u2265 90 mmHg with no\n             hypertension medication"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "50 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 16, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01880931", 
            "org_study_id": "4-2013-0239"
        }, 
        "intervention": {
            "arm_group_label": [
                "Normotensive patients", 
                "Hypertensive patients"
            ], 
            "description": "The effect site concentration of remifentanil", 
            "intervention_name": "Remifentanil", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Remifentanil"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 25, 2013", 
        "location": {
            "contact": {
                "email": "KIMSY326@yuhs.ac", 
                "last_name": "So Yeon Kim, MD, PhD", 
                "phone": "82-2-2227-4470"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of"
                }, 
                "name": "Department of Anesthesiology and Pain Medicine and Anesthesia and Pain Research Institute, Yonsei University College of Medicine"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "overall_contact": {
            "last_name": "So Yeon Kim, MD, PhD", 
            "phone": "82-2-2227-4470"
        }, 
        "overall_official": {
            "affiliation": "Department of Anesthesiology and Pain Medicine and Anesthesia and Pain Research Institute, Yonsei University College of Medicine", 
            "last_name": "So Yeon Kim, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "The effect site concentration of remifentanil for preventing QTc interval prolongation", 
            "safety_issue": "Yes", 
            "time_frame": "2 min"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01880931"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Severance Hospital", 
            "investigator_full_name": "So Yeon Kim", 
            "investigator_title": "Assistant professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Severance Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Severance Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}